Imaging Biomarkers in Parkinson's Disease and Movement Disorders: Emerging Insights from Multimodal Neuroimaging.
While these multimodal biomarkers offer unprecedented mechanistic insights into disease progression and therapeutic response, their ultimate value depends on successful clinical translation, it would be essential for the field to prioritize standardized acquisition protocols, automated post-processing pipelines, and ac...